Fernando Pérez-Ruiz

University of the Basque Country — Spain

Medicine · Health Sciences

67h-index73.0kcitations306works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gout, Hyperuricemia, Uric Acid(217), Case Reports on Hematomas(80), Spondyloarthritis Studies and Treatments(49), Urticaria and Related Conditions(46), Rheumatoid Arthritis Research and Therapies(16)

Publications293 total

The 16th European Crystal Network (ECN) Workshop—2025 ECN Abstract Proceedings
Gout Urate and Crystal Deposition Disease·2025Open Access
Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout
Arthritis Care & Research·2025· 1 citedOpen Access
Acute kidney injury in gout: prevalence and risk factors through two decades
Exploration of Musculoskeletal Diseases·2025Open Access
Correction: The ‘FebBenz’ approach for severe difficult-to-treat gout
Exploration of Musculoskeletal Diseases·2025Open Access
POS0880 DOES PORTABLE ULTRASOUND ASSIST IN THE DIAGNOSIS AND TREATMENT OF HOSPITALIZED RHEUMATOLOGIC PATIENTS
Annals of the Rheumatic Diseases·2025Open Access
The ‘FebBenz’ approach for severe difficult-to-treat gout
Exploration of Musculoskeletal Diseases·2025Open Access
[Artículo traducido] Análisis costes-efectividad del tocilizumab biosimilar subcutáneo en pacientes con artritis reumatoide en España
Farmacia Hospitalaria·2025Open Access
Transition from reference adalimumab to biosimilar SB5 in patients with rheumatoid arthritis: sub-analysis of Spanish patients in the PROPER study
Exploration of Musculoskeletal Diseases·2025· 2 citedOpen Access
Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies
Contemporary Clinical Trials·2025· 1 cited
Cost-effectiveness analysis of subcutaneous biosimilar tocilizumab in patients with rheumatoid arthritis in Spain
Farmacia Hospitalaria·2024· 1 citedOpen Access
EE376 Rheumatoid Arthritis, Cost-Effectiveness Analysis of Biosimilar Tocilizumab in Spain
Value in Health·2024Open Access
Publisher Correction: A genome-wide association analysis reveals new pathogenic pathways in gout
Nature Genetics·2024· 1 citedOpen Access
A genome-wide association analysis reveals new pathogenic pathways in gout
Nature Genetics·2024· 67 citedOpen Access
The 15th European Crystal Network (ECN) Workshop—2024 ECN Abstract Proceedings
Gout Urate and Crystal Deposition Disease·2024· 1 citedOpen Access
Prevalence and factors associated to calcium pyrophosphate arthritis in patients with gout
Exploration of Musculoskeletal Diseases·2024· 1 citedOpen Access
Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers
Exploration of Musculoskeletal Diseases·2024· 2 citedOpen Access
http://www.sanipe.es/OJS/index.php/RESP/article/view/676/1324
Revista Española de Sanidad Penitenciaria·2024Open Access
POS1031 COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB BIOSIMILAR IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SPAIN
Annals of the Rheumatic Diseases·2024
POS0941 INTENSIVE REDUCTION OF SERUM URIC ACID WITH URICASE EFFECT THROUGH THE COMBINATION OF BENZBROMARONE AND FEBUXOSTAT IN PATIENTS WITH DIFFICULT-TO-TREAT TOPHACEOUS GOUT
Annals of the Rheumatic Diseases·2024
14th European Crystal Network (ECN) Workshop—Abstract Proceedings
Gout Urate and Crystal Deposition Disease·2024· 2 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Nicola Dalbeth(17), Thomas Bardin(13), William J. Taylor(13), Tim Jansen(12), Frédéric Lioté(10), Jasvinder A. Singh(10), Francisca Sivera(10), H. Ralph Schumacher(9), George Nuki(9), Pascal Richette(8), Michael Doherty(8), Eliseo Pascual(8), Till Uhlig(8), Tuhina Neogi(8), Hyon K. Choi(8), M. Janssen(7), Ana María Herrero-Beites(7), Leonardo Punzi(6), Alexander So(6), N. Lawrence Edwards(6)